Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesImprovement in tumour control probability with active breathing control and dose escalation: A modelling study
Radiotherapy and Oncology, 06/22/09
Partridge M et al. - A near-doubling of tumour control probability is possible with modest dose escalation, which can be achieved with no extra increase in lung dose if deep inspiration breath-hold techniques are used.
Related Articles
Treatment of Aggressive Fibromatosis: the Experience of a Single Institution
Clinical Oncology, 11/12/09
Relevance Score: 65%
Cigarette smoke extract immobilizes human spermatozoa and induces sperm apoptosis
Reproductive BioMedicine Online, 11/24/09
Relevance Score: 64%
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours
European Journal of Cancer, 11/12/09
Relevance Score: 64%
Analysis of Candidate Genes in Occurrence and Growth of Colorectal Adenomas
Journal of Oncology, 11/02/09
Relevance Score: 64%
In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy
Journal of Neuro-Oncology, 10/01/09
Relevance Score: 64%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Port central venous catheters–associated bloodstream infection during outpatient-based chemotherapy
Medical Oncology, 12/17/09
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer
European Journal of Cancer, 12/16/09
A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status
Oncology (Karger), 12/16/09
Sponsor
Article Search
Sponsor
Sponsor